KINETA

Kineta is a biotechnology company engaging in the discovery and development of antiviral therapies and immune-modulating drugs for the treatment of RNA viruses that include hepatitis C, influenza, West Nile virus, and the common cold. Kineta was founded in 2008 and is based in Seattle, Washington.

KINETA

Social Links:

Facebook

Twitter

Industry:

Biotechnology Medical Device Therapeutics

Founded:

2008-01-01

Address:

Seattle, Washington, United States

Country:

United States

Website Url:

http://www.kinetabio.com

Total Employee:

11+

Status:

Active

Contact:

(206)378-0400

Email Addresses:

[email protected]

Total Funding:

81.48 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Domain Not Resolving

Similar Organizations

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

Current Employees Featured

charles-magness_image

Charles Magness
Charles Magness Co-Founder,President @ Kineta
Co-Founder,President
2007-01-01

craig-philips_image

Craig Philips
Craig Philips President @ Kineta
President
2013-01-01

shawn-iadonato_image

Shawn Iadonato
Shawn Iadonato Chief Executive Officer @ Kineta
Chief Executive Officer
2016-01-01

michael-banks_image

Michael Banks
Michael Banks CFO @ Kineta
CFO

ken-north_image

Ken North
Ken North SVP, Corporate Development @ Kineta
SVP, Corporate Development
2008-11-01

eric-tarcha_image

Eric Tarcha
Eric Tarcha SVP Translational Development @ Kineta
SVP Translational Development

jacques-bouchy_image

Jacques Bouchy
Jacques Bouchy SVP Business Development and Corporate Communications @ Kineta
SVP Business Development and Corporate Communications
2016-01-01

thierry-guillaudeux_image

Thierry Guillaudeux
Thierry Guillaudeux Executive Vice President and Chief Scientific Officer @ Kineta
Executive Vice President and Chief Scientific Officer
2022-02-01